| Q47933850 | A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: monitoring of testosterone replacement therapy with testosterone buciclate |
| Q42668582 | An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men. |
| Q35871132 | Androgen replacement therapy: present and future |
| Q37798945 | Clinical trials in male hormonal contraception |
| Q51027296 | Correlation between serum testosterone level and concentrations of copper and zinc in hair tissue. |
| Q35172636 | Development of methods of male contraception: impact of the World Health Organization Task Force |
| Q24680356 | Discovery and therapeutic promise of selective androgen receptor modulators |
| Q73258750 | Efficacy and acceptability of testosterone implants, alone or in combination with a 5alpha-reductase inhibitor, for male hormonal contraception |
| Q73342658 | Evaluation of efficacy, safety, and reversibility of combination regimen of cyproterone acetate and testosterone buciclate in bonnet monkey |
| Q33895560 | Hormone substitution in male hypogonadism |
| Q35618348 | Inhibition of follicle-stimulating hormone-induced preovulatory follicles in rats treated with a nonsteroidal negative allosteric modulator of follicle-stimulating hormone receptor |
| Q44771171 | Intratesticular morphometric, cellular and endocrine changes in dromedary bulls exhibiting azoospermia |
| Q71337567 | Male contraception |
| Q35556839 | New long-acting androgens |
| Q73549953 | Pharmacokinetics of 7 alpha-methyl-19-nortestosterone (MENT) delivery using subdermal implants in healthy men |
| Q34646568 | Recent advances in hormonal male contraception |
| Q37172483 | Serum total testosterone level and identification of late-onset hypogonadism: a community-based study |
| Q28244508 | Testosterone hormone replacement therapy: state-of-the-art and emerging technologies |
| Q33913912 | Testosterone therapy in men: clinical and pharmacological perspectives |
| Q28258718 | Testosterone treatment comes of age: new options for hypogonadal men |
| Q37718605 | Update on male hormonal contraception: is the vasectomy in jeopardy? |
| Q41688915 | Use of Exogenous Testosterone for the Treatment of Male Factor Infertility: A Survey of Nigerian Doctors. |
| Q35605057 | Use of progestins in male contraception |
| Q80295513 | [Non-deferential male contraception: review of the literature] |